Your Biopharmaceutical Development and Manufacturing Partner

Nanotherapeutics Grants Worldwide Rights to Amend Surgical, Inc. for NanoFUSE® DBM

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, today announced that the Company has granted an exclusive worldwide license to its proprietary bone void filler product, NanoFUSE® DBM (demineralized bone matrix), to Alachua, FL-based Amend Surgical, Inc. Financial terms of the transaction were not disclosed, however, under the license agreement, Nanotherapeutics will become a minority shareholder in Amend Surgical.


Read Full article at BUSINESS WIRE

Copyright 2017 NANOTHERAPEUTICS, INC.  All rights reserved.